Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma

被引：0

作者：

Figura, N. ^{[1
]}

Sim, A. ^{[1
]}

Dahiya, S. ^{[2
,3
]}

Lutfi, F. ^{[2
,3
]}

Rapoport, A. ^{[2
,3
]}

Mohindra, P. ^{[4
]}

Dohm, A. ^{[1
]}

Chavez, J. ^{[5
]}

Shah, B. ^{[5
]}

Khimani, F. ^{[6
]}

Lazaryan, A. ^{[6
]}

Davila, M. ^{[6
]}

Bachmeier, C. ^{[6
]}

Nishihori, T. ^{[6
]}

Liu, H. ^{[6
]}

Kim, S. ^{[1
]}

Locke, F. ^{[6
]}

Jain, M. ^{[6
]}

Robinson, T. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA

[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA

[3] Univ Maryland, Sch Med, Greenebaum Comprehens Ctr, Baltimore, MD 21201 USA

[4] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Bone & Marrow Transplant & Cellular Immunoth, Tampa, FL USA

来源：

RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO-1075

引用

页码：S894 / S895

页数：2

共 50 条

[31] Bridging Radiotherapy for Patients with Limited (<5 Disease Sites) Relapsed/Refractory B-Cell Non -Hodgkin Lymphoma Prior to CAR T-Cell Therapy
Saifi, O.
Breen, W.
Lester, S. C.
Rule, W. G.
Stish, B. J.
Rosenthal, A.
Munoz, J.
Lin, Y.
Johnston, P.
Ansell, S. M.
Paludo, J.
Khurana, A.
Bisneto, J. Villasboas
Wang, Y.
Iqbal, M.
Moustafa, M. Alhaj
Murthy, H. S.
Kharfan-Dabaja, M.
Hoppe, B. S.
Peterson, J. L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S64 - S65
[32] Bridging before CAR T-cell therapy-a new opportunity for radiotherapy?
Oertel, Michael
Eich, Hans Theodor
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (12) : 1154 - 1156
[33] Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Ababneh, Hazim S.
Ng, Andrea K.
Frigault, Matthew J.
Jacobson, Caron A.
Patel, Chirayu G.
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1837 - 1840
[34] Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Ababneh, Hazim
Ng, Andrea
Frigaul, Matthew
Jacobson, Caron
Patel, Chirayu
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S26 - S26
[35] CAR T-Cell Therapies in Mantle Cell Lymphoma, Hints of Cure
Wang, Michael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S189 - S191
[36] Glabellar mass in a case of mantle-cell lymphoma treated by CAR T-cell therapy
Munoz, Javier
Wang, Michael
LANCET, 2023, 401 (10381): : 1037 - 1038
[37] Advances in CAR T-cell therapy for treating patients with mantle cell lymphoma: a critical appraisal
Amin, Ruhul
Darwin, Ronald
Chakraborty, Sandip
Dey, Abhijit
Dhama, Kuldeep
Emran, Talha Bin
INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 3742 - 3744
[38] CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience
Ahmed, Gulrayz
Alsouqi, Aseel
Szabo, Aniko
Samples, Laura
Shadman, Mazyar
Awan, Farrukh T.
Rojek, Alexandra E.
Riedell, Peter A.
Iqbal, Madiha
Fenske, Timothy S.
Kharfan-Dabaja, Mohamed A.
Ito, Sawa
Hamadani, Mehdi
BLOOD ADVANCES, 2024, 8 (13) : 3528 - 3531
[39] CAR T-cell therapy versus allogeneic HSCT for relapsed or refractory mantle cell lymphoma
Iacoboni, Gloria
Dietrich, Sascha
Liebers, Nora
LANCET HAEMATOLOGY, 2023, 10 (12): : E951 - E952
[40] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Iacoboni, Gloria
Rejeski, Kai
Camacho, Lina
Chiappella, Annalisa
Guadagnuolo, Serafina
Lopez Corral, Lucia
Bastos-Oreiro, Mariana
Delgado Serrano, Javier
Schmidt, Christian
Carpio, Cecilia
Luis Reguera, Juan
Kwon, Mi
Martin Garcia-Sancho, Alejandro
Luigi Zinzani, Pier
Corradini, Paolo
Subklewe, Marion
Barba, Pere
BLOOD, 2021, 138

← 1 2 3 4 5 →